Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_336b63f79c2ddba567f69f4962c8a437 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-455 |
filingDate |
2013-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a582a6bde6f6e11ebbddd01702aa3575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bef951a5cb25ae6a6869f9b29d868a6 |
publicationDate |
2014-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2014068516-A2 |
titleOfInvention |
A method of managing urolithiasis and related urological disorders |
abstract |
The present disclosure relates to a method of managing urolithiasis or related urological disorders in a subject in need thereof, using pharmaceutical composition comprising trigonelline or its derivative(s) and 4-hydroxyisoleucine or its derivative(s), optionally along with excipient(s). |
priorityDate |
2012-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |